I don't think this would look good for Prana and Life if this...

I don't think this would look good for Prana and Life if this was to blow upwards, as investors see Prana may have the complete answer to antibiotic resistant bacteria. Considering the deal made with Life some time after the UQ publication. I would not expect Prana to talk this up just now. The question now is, should Prana move a PBT2 antibiotic adjuvant program to the front of the Parkinson's program, or just sit on their hands while everyone catches up as usual.